Question 1

What is Pinealon?

Accepted Answer

Pinealon is a synthetic tripeptide (Ala-Glu-Asp) developed as a pineal gland peptide bioregulator by Khavinson and colleagues at the St. Petersburg Institute of Bioregulation. It belongs to the class of short peptide bioregulators developed from the Russian peptide bioregulator research tradition. Pinealon has been studied in preclinical models for neuroprotective effects, antioxidant activity in brain tissue, and cognitive function in aged rodent cohorts. It is for in vitro research use only.

Question 2

How does Pinealon work in research models?

Accepted Answer

In preclinical research models, Pinealon has been documented modulating pineal gland regulatory pathways and antioxidant enzyme activity including SOD and catalase in brain tissue. Published research also characterizes effects on cell cycle regulatory proteins including PCNA in neural cell culture systems. Aging model research documents reductions in oxidative stress markers and cognitive function improvements in aged rodent cohorts. See /how-pinealon-works/ for the complete mechanism overview.

Question 3

What has Pinealon been studied for in published research?

Accepted Answer

Published research has examined Pinealon in brain antioxidant studies (SOD and catalase activation), cognitive aging paradigms in rodent models (spatial learning and memory), pineal gland biology and melatonin pathway regulation in animal models, neuroproliferative cell culture research, and long-term rodent cohort studies examining longevity and age-related pathology.

Question 4

What is Pinealon's half-life in research models?

Accepted Answer

Pinealon as a tripeptide is subject to proteolytic degradation in plasma, resulting in relatively rapid clearance. Published Khavinson group research documents protocol designs based on these pharmacokinetic considerations, with administration frequency in preclinical studies reflecting the short plasma half-life of the tripeptide. Specific half-life values from published pharmacokinetic characterization should be consulted for model-specific parameter design.

Question 5

How is Pinealon stored for research use?

Accepted Answer

Research-grade Pinealon should be stored as lyophilized powder at -20 degrees Celsius for long-term stability. Short-term storage at 2 to 8 degrees Celsius under dry conditions is acceptable. Reconstituted solutions should be prepared in sterile aqueous vehicle and used within established handling timeframes. Repeated freeze-thaw cycles should be avoided to maintain peptide integrity in research applications.

Question 6

What purity standard should research-grade Pinealon meet?

Accepted Answer

Research-grade Pinealon should be characterized by HPLC purity analysis with at least 98% purity and mass spectrometry molecular weight confirmation. Certificate of Analysis should include purity result, sequence confirmation, and batch identification. As with all tripeptide bioregulators, researchers should verify the correct amino acid sequence (Ala-Glu-Asp) in COA documentation before in vitro use.

Question 7

Is Pinealon water soluble?

Accepted Answer

Pinealon has good water solubility as a tripeptide and is typically reconstituted in sterile water or physiological saline for research applications. Published Khavinson group preclinical protocols document aqueous vehicle preparation for animal model administration. For cell culture research, reconstitution in sterile water with dilution in culture media is the standard approach.

Question 8

What relationship does Pinealon have with melatonin in published research?

Accepted Answer

Published research from Khavinson and colleagues documents Pinealon modulating pineal gland secretory function with effects on melatonin synthesis pathway parameters in aged rodent models. As a peptide derived from the pineal gland research tradition, Pinealon is studied in the context of pineal biology and circadian regulation. Published research has characterized changes in nocturnal melatonin levels in aged animals receiving Pinealon treatment relative to untreated aging controls.

Question 9

How does Pinealon compare to Epithalon in the peptide bioregulator research literature?

Accepted Answer

Pinealon and Epithalon are both peptide bioregulators studied by Khavinson and colleagues, but with distinct mechanistic profiles. Epithalon is primarily studied for telomerase activation and replicative lifespan extension in somatic cells. Pinealon is studied for antioxidant activity in brain tissue and pineal gland regulatory effects. They overlap in the broader longevity research context but address different biological endpoints in published research.

Question 10

What cognitive aging research has been published for Pinealon?

Accepted Answer

This compound is for in vitro research use only. Published aged rodent cognition studies have documented Pinealon improving spatial memory and learning task performance relative to untreated aged control groups. Researchers have correlated behavioral improvements with reduced oxidative stress markers in brain tissue, measured through lipid peroxidation assays and antioxidant enzyme activity. Primary publications from the Khavinson group should be consulted for specific aged animal protocol parameters.

Question 11

What is the molecular weight of Pinealon?

Accepted Answer

Pinealon (Ala-Glu-Asp) as a tripeptide has a molecular weight of approximately 347 Daltons as the free peptide. This small molecular weight is consistent with favorable BBB penetration characteristics by standard permeability criteria. COA mass spectrometry confirmation should match this expected value for the correct Ala-Glu-Asp sequence.

Question 12

What is the amino acid sequence of Pinealon?

Accepted Answer

Pinealon is a tripeptide with the sequence Ala-Glu-Asp (alanine, glutamic acid, aspartic acid). This sequence was developed from the Khavinson group's research on pineal gland peptide fractionation and is the synthetic version of the active fragment from pineal bioregulator research. Sequence confirmation by mass spectrometry in COA documentation is essential for verifying the correct compound.

Question 13

Does Pinealon cross the blood-brain barrier in preclinical research?

Accepted Answer

Pinealon's tripeptide size (roughly 347 Daltons) is consistent with BBB penetration capacity by molecular weight criteria. Published research documents direct brain tissue antioxidant effects and cognitive endpoint changes in rodent models, which is consistent with CNS access. The Khavinson group's published mechanistic characterization of antioxidant enzyme changes in brain tissue specifically suggests CNS distribution in their in vivo model protocols.

Question 14

What purity should researchers look for when sourcing Pinealon?

Accepted Answer

Research-grade Pinealon should meet at least 98% purity by HPLC with mass spectrometry confirmation of the tripeptide molecular weight around 347 Da. As a three-amino acid peptide, high-purity synthesis is more achievable than for longer compounds. Researchers should still require batch-specific COA documentation confirming the Ala-Glu-Asp sequence, since tripeptide sequence variants with similar mass could potentially be confused without explicit sequence verification.

Question 15

How do researchers verify a certificate of analysis for Pinealon?

Accepted Answer

A valid Pinealon COA should include HPLC purity result with chromatogram, mass spectrometry data confirming molecular weight around 347 Da for the Ala-Glu-Asp sequence, batch number, and testing date. Cross-referencing the MS value against the expected tripeptide mass is straightforward for this small compound. Batch-specific documentation rather than a generic reference certificate is the appropriate standard for research sourcing.

Question 16

What research areas involve Pinealon and oxidative stress in the brain?

Accepted Answer

Published Pinealon research has characterized antioxidant enzyme activation in brain tissue as a primary endpoint, with SOD, catalase, and glutathione peroxidase activities measured in published Khavinson group rodent studies. Lipid peroxidation products including malondialdehyde have been measured as oxidative stress markers in brain tissue of aged rodents receiving Pinealon. These antioxidant endpoints are the most consistently documented in the published Pinealon literature.

Question 17

What does HPLC verification mean for Pinealon research quality?

Accepted Answer

HPLC verification for Pinealon characterizes the purity of the tripeptide relative to synthesis byproducts and other small-molecule impurities. Because Pinealon is a short three-amino acid peptide, synthesis purity is generally more achievable than for longer compounds, and researchers should expect results at or above 99% from quality suppliers. A COA showing the full chromatogram alongside the purity percentage provides complete analytical documentation.

Question 18

Why does batch-to-batch consistency matter for Pinealon research?

Accepted Answer

Batch consistency for Pinealon matters for antioxidant enzyme and cognitive research applications where compound-specific activity must be reliably attributed. Variable impurity content across batches could potentially contribute to non-specific antioxidant effects that confound the Pinealon-specific findings. Researchers running multiple experiments over time should document batch numbers and compare COA purity data to confirm consistency.

Question 19

Has Pinealon been studied in combination with other Khavinson peptide bioregulators?

Accepted Answer

The Khavinson research program has studied combinations of short peptide bioregulators targeting different organ systems in their published longevity research, including pineal, thymic, and cortical peptide combinations. Published rodent longevity studies from the St. Petersburg Institute have used multi-peptide protocols covering different organ system targets. Pinealon as a pineal bioregulator has been studied both alone and as part of these broader peptide combination protocols.

Question 20

What animal models are used in published Pinealon longevity research?

Accepted Answer

Published Pinealon longevity and aging research has primarily used Wistar rat and C57BL/6 mouse cohort studies, with Khavinson group publications documenting survival curves, age-related pathology incidence, and antioxidant enzyme activity changes. Aged rodent groups receiving Pinealon have been compared to untreated aging controls and sometimes to young control groups for baseline context. Published protocols from the Khavinson group provide specific model parameters.

Question 21

What published research has examined Pinealon and neuroproliferative effects?

Accepted Answer

Published cell culture research from the Khavinson group has examined Pinealon effects on proliferating neural cells, characterizing PCNA (proliferating cell nuclear antigen) expression changes as an endpoint for cell cycle activity. These in vitro studies complement the in vivo aging model research and provide mechanistic insight into how Pinealon may influence neural tissue at the cellular level. Published methodology sections in these studies document the specific cell culture systems and concentration ranges used.

Question 22

Where can researchers source Pinealon for in vitro research?

Accepted Answer

Research-grade Pinealon for in vitro use is available from Spartan Peptides with at least 98% HPLC-verified purity and batch-specific Certificate of Analysis documentation. All Pinealon is for in vitro research use only. Researchers should confirm the Ala-Glu-Asp sequence in COA documentation before in vitro neuroprotection or antioxidant enzyme research applications.

Question 23

What's the difference between Pinealon and other Khavinson-family tripeptide bioregulators?

Accepted Answer

Khavinson's peptide bioregulator research program includes tripeptides targeting different organs: Pinealon (Ala-Glu-Asp) from pineal tissue, Vilon (Lys-Glu) for immune thymus, Epithalon (Ala-Glu-Asp-Gly) as a tetrapeptide from pineal research. Each bioregulator was derived from fractionation of the corresponding organ tissue and studied for effects on that organ system. This organ-targeting specificity is the organizing principle of the Khavinson bioregulator research program in published literature.

Question 24

What sourcing considerations apply to Pinealon for in vitro research?

Accepted Answer

Pinealon's tripeptide simplicity makes high-purity synthesis achievable, but researchers should still require batch-specific COA documentation with both HPLC purity and mass spectrometry confirmation. Correct sequence verification is important since Pinealon (Ala-Glu-Asp) and Epithalon (Ala-Glu-Asp-Gly) differ by a single glycine, and suppliers must demonstrate they've synthesized the correct tripeptide. Spartan Peptides provides research-grade Pinealon with full COA documentation for in vitro research applications.

GLP-3(Reta) | Triple-Agonist Metabolic Research

NAD+ 750mg | Cellular Energy & DNA Repair Research

MOTS-c | Mitochondrial Metabolism Research Peptide

BPC-157 5mg | Tissue Repair & Gut Health Research

Pinealon Frequently Asked Questions

Explore Full Research Index